ADVIK LABORATORIES LTD. Share Price

ADVIK LABORATORIES LTD. Share Price

BSE: 531686
|
Pharmaceuticals
|
S Cap
₹ 1.99
+0.00 (0.00%)
1D
Last updated 31 Aug, 2026, 15:03 IST
--
0.00% up today
--
1D LOW
1D HIGH

ADVIK LABORATORIES LTD. Returns Calculator

Circuit
L
H
₹1.90
₹2.08
52-week
L
H
₹1.57
₹2.08

About ADVIK LABORATORIES LTD.

ADVIK LABORATORIES LTD. Share Price
ISIN
INE537C01019
Sector Market Cap
₹ 3.80 Cr

ADVIK LABORATORIES LTD. Financial Highlights

  • Revenue: ADVIK LABORATORIES LTD. reported revenue of ₹0.04 crore in FY26 vs ₹0.05 crore in FY25. It showed a decrease of 20.00% on a yearly basis.
  • Operating Profit: ADVIK LABORATORIES LTD. reported an operating loss of ₹1.06 crore in FY26 vs ₹0.86 crore in FY25. It showed a decrease of 23.26% on a year-on-year basis.
  • Net Profit: ADVIK LABORATORIES LTD. reported a net loss of ₹1.02 crore in FY26 vs ₹0.90 crore in FY25. It showed a decrease of 13.33% on a yearly basis.

ADVIK LABORATORIES LTD. Quarterly Result Highlights

  • ADVIK LABORATORIES LTD. reported revenue of ₹0.00 crore in Jun 2026, compared with ₹0.04 crore in Mar 2026, representing a decrease of 100.00% on a quarter-on-quarter (QoQ) basis.
  • ADVIK LABORATORIES LTD. reported an operating loss of ₹0.24 crore in Jun 2026, compared with ₹0.37 crore in Mar 2026, representing an increase of 35.14% on a quarter-on-quarter (QoQ) basis.
  • ADVIK LABORATORIES LTD. reported a loss of ₹0.24 crore in Jun 2026, compared with ₹0.36 crore in Mar 2026, reflecting an increase of 33.33% on a QoQ basis.
  • The earnings per share (EPS) of ADVIK LABORATORIES LTD. stood at ₹0.47 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
35.89%
FII
0.00%
Other DII
0.58%
Retail and other
63.53%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
3.80
P/E
-3.69
P/B
53.27
ROE
-1,489.05%
D/E
109.84
ROCE
-13.92%
Div. Yield
0.00%
EPS(TTM)
-0.53
Turnover
0.00
EV/EBITDA
-12.44
Net Margin
0.00%
Op. Margin
0.00%
ROA
-12.26%
Quick Ratio
0.00
Curr. Ratio
2.81
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
MPS Pharmaa outperforming all market indices
Step 1 of 5
Valuation
Overvalued
MPS Pharmaa appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,47,236.0036.485.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,49,673.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,521.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,484.0032.863.2011.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,04,604.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Aurobindo Pharma96,030.6025.982.549.25%0.1911.76%394.820.24%0.3841.58
Dr. Reddy's Laboratories95,220.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Lupin94,882.7017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma92,769.9045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ADVIK LABORATORIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.00₹0.00₹0.00₹0.03
Other Income₹0.05₹0.09₹0.02₹0.26
Total Revenue₹0.05₹0.09₹0.02₹0.29
Total Expenses₹0.91₹0.95₹1.09₹1.22
Profit Before Tax-₹0.86-₹0.85-₹1.07-₹0.93
Tax₹0.03-₹0.02-₹0.02-₹0.79
Profit After Tax-₹0.90-₹0.83-₹1.05-₹0.14
EPS - Basic-₹0.47-₹0.43-₹0.55-₹0.07
EPS - Diluted-₹0.47-₹0.43-₹0.55-₹0.07

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.89-₹0.82-₹1.04-₹0.12
Income before WC changes-₹0.74-₹0.69-₹0.90-₹0.04
Change in Assets₹0.07-₹0.02-₹0.08₹0.17
Change in Liabilities₹0.10₹0.08₹0.12-₹4.47
Change in WC₹0.17₹0.06₹0.04-₹4.30
Cash flow from Operations-₹0.57-₹0.63-₹0.87-₹4.34
Cash flow from Investing₹0.38₹0.12-₹0.10₹0.46
Cash flow from Financing₹0.18₹0.51₹0.96₹3.88
Total Cash Flow₹0.00₹0.00-₹0.01₹0.00
Cash (Start of the year)₹0.01₹0.01₹0.01₹0.01
Cash (End of the year)₹0.00₹0.01₹0.01₹0.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹7.28₹7.81₹8.08₹8.13
Current Assets₹2.05₹2.12₹2.10₹2.03
Total Assets₹9.33₹9.94₹10.19₹10.16
Current Liabilities₹8.07₹7.74₹7.17₹6.08
Net Current Asset-₹6.02-₹5.62-₹5.06-₹4.05
Non-Current Liabilities₹0.18₹0.22₹0.23₹0.25
Equity Capital₹1.08₹1.97₹2.79₹3.83
Total Equity & Liabilities₹9.33₹9.94₹10.19₹10.16
* All values are in INR Crore
Qty
Bid
2000
1.99
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 2000
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
1
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
100
Bullish
ATR (14)
0.02
Neutral
STOCH(9,6)
100
Bearish
ADX(9)
100
Bearish
ROC(12)
15.03
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
1.95
1.95
10D
1.89
1.9
20D
1.8
1.84
50D
1.87
0
100D
1.87
0

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ADVIK LABORATORIES LTD. Share Price
ADVIK LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

ADVIK LABORATORIES LTD. Share Price FAQs

ADVIK LABORATORIES LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837